Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany

被引:0
|
作者
Vogt, D. [1 ]
Haritoglou, C. [2 ]
Nicoletti, V. [1 ]
Kortuem, F. C. [3 ]
Deiters, V. [4 ]
Hoerauf, H. [5 ]
Wolf, A. [1 ]
Schumann, R. G. [1 ,6 ]
机构
[1] Univ Klinikum Ulm, Klin Augenheilkunde, Prittwitzstr 43, D-89075 Ulm, Germany
[2] Augenklin Herzog Carl Theodor, Munich, Germany
[3] Univ Klinikum Tubingen, Augenklinik, Tubingen, Germany
[4] Ludwig Maximilians Univ Munchen, Augenklin Univ Munchen, Munich, Germany
[5] Univ Med Gottingen, Augenklinik, Gottingen, Germany
[6] Augenzentrum & Gefassmed Munchen Schwabing, Munich, Germany
来源
OPHTHALMOLOGIE | 2024年 / 121卷 / 12期
关键词
Macular hole; Vitrectomy; Vitreolysis; Vitreomacular traction; Ocriplasmin; PARS-PLANA VITRECTOMY; PNEUMATIC VITREOLYSIS; OCRIPLASMIN;
D O I
10.1007/s00347-024-02118-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To evaluate the different treatment strategies for eyes with vitreomacular traction (VMT) and macular holes (MF) regarding the indications and initiation of treatment. ObjectiveThe aim of this study is to facilitate clinical decision making by presenting the opinions of experienced retinal specialists in the context of the current literature and the changed approval situation for ocriplasmin. Material and methods: Members of the German Retina Society (RG) were questioned in an online survey. Based on a literature review a 100-question questionnaire was created and sent to all members of the RG via an electronic link to the online platform "LimeSurvey". Voluntary participation was possible from 15 October 2021 to 15 November 2021. Data collection and statistical analysis were anonymized. Results: The responses of the 115 participants were congruent with the presentation of the new S1 guidelines on this topic. The indications for active treatment of focal VMT without MF were postponed in favor of watchful waiting, with the individual symptoms of the patient playing a major role in the proposed temporal management. The results on the indications for vitrectomy are consistent and convincingly confirm the opinions on the efficacy and risk assessment of this therapeutic procedure. Conclusion: The results presented provide an overview of the consensus and controversies in the current treatment options for VMT and MF. With the help of a homogeneous and experienced group of retinal experts, it was possible to develop individual treatment strategies.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 50 条
  • [31] Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trial
    Thomas, Akshay S.
    Duchateau, Luc
    Kozma-Wiebe, Petra
    Jaffe, Glenn
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (07) : 1012 - 1017
  • [32] Current management strategies for atypical macular holes
    Marlow, Elizabeth D.
    Mahmoud, Tamer H.
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2021, 11 (03) : 221 - 231
  • [33] TREATMENT OF RETINAL DETACHMENTS DUE TO MACULAR HOLES
    GRECO, GM
    BONAVOLONTA, G
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1987, 7 (03): : 177 - 179
  • [34] TREATMENT OF RETINAL DETACHMENTS SECONDARY TO MACULAR HOLES
    LANDERS, MB
    YAMANASHI, BS
    SOUTHERN MEDICAL JOURNAL, 1973, 66 (12) : 1371 - 1374
  • [35] TREATMENT OF RETINAL-DETACHMENT WITH MACULAR HOLES
    CLARKSON, JG
    INTERNATIONAL OPHTHALMOLOGY, 1982, 5 (02) : 99 - 99
  • [36] Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy
    Maier, M.
    Abraham, S.
    Frank, C.
    Lohmann, C. P.
    Feucht, N.
    OPHTHALMOLOGE, 2017, 114 (02): : 148 - 154
  • [37] TREATMENT OF RETINAL DETACHMENTS DUE TO MACULAR HOLES
    HARRIS, MJ
    DEBUSTROS, S
    MICHELS, RG
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1984, 4 (03): : 144 - 147
  • [38] Cost Evaluation of Surgical and Pharmaceutical Options in Treatment for Vitreomacular Adhesions and Macular Holes
    Chang, Jonathan S.
    Smiddy, William E.
    OPHTHALMOLOGY, 2014, 121 (09) : 1720 - 1726
  • [39] ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES Results of OVIID-1 Trial
    Tadayoni, Ramin
    Holz, Frank G.
    Zech, Christophe
    Liu, Xin
    Spera, Claudio
    Stalmans, Peter
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (12): : 2341 - 2352
  • [40] Macular holes. Overview of the current state of knowledge on pathogenesis and treatment strategies
    Tornambe, P
    Augustin, AJ
    OPHTHALMOLOGE, 2002, 99 (08): : 601 - 608